M. ERGÜL Et Al. , "p Critical Residues in Hsp70 Nucleotide Binding Domain for Challenges in Drug Design," CURRENT PROTEOMICS , vol.19, no.1, pp.83-90, 2022
ERGÜL, M. Et Al. 2022. p Critical Residues in Hsp70 Nucleotide Binding Domain for Challenges in Drug Design. CURRENT PROTEOMICS , vol.19, no.1 , 83-90.
ERGÜL, M., AKTAN, F., & Tutar, Y., (2022). p Critical Residues in Hsp70 Nucleotide Binding Domain for Challenges in Drug Design. CURRENT PROTEOMICS , vol.19, no.1, 83-90.
ERGÜL, MUSTAFA, FÜGEN AKTAN, And Yusuf Tutar. "p Critical Residues in Hsp70 Nucleotide Binding Domain for Challenges in Drug Design," CURRENT PROTEOMICS , vol.19, no.1, 83-90, 2022
ERGÜL, MUSTAFA Et Al. "p Critical Residues in Hsp70 Nucleotide Binding Domain for Challenges in Drug Design." CURRENT PROTEOMICS , vol.19, no.1, pp.83-90, 2022
ERGÜL, M. AKTAN, F. And Tutar, Y. (2022) . "p Critical Residues in Hsp70 Nucleotide Binding Domain for Challenges in Drug Design." CURRENT PROTEOMICS , vol.19, no.1, pp.83-90.
@article{article, author={MUSTAFA ERGÜL Et Al. }, title={p Critical Residues in Hsp70 Nucleotide Binding Domain for Challenges in Drug Design}, journal={CURRENT PROTEOMICS}, year=2022, pages={83-90} }